Abstract
Goals
In this theoretical paper, we present the Edmonton Fatigue Framework (EFF), a new framework for the study of tiredness, fatigue, and exhaustion in advanced cancer.
Materials and methods
The Fatigue Adaptation Model (FAM), the starting point for the EFF, was drawn from a literature review pertaining to fatigue in depression, chronic fatigue syndrome, cancer, shift workers, and athletes published in the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval System Online (MEDLINE), PubMed, PsychINFO, SPORTdiscus, and CancerLit between 1995 and 2004, and from seven qualitative studies conducted by our group. The EFF, an elaboration of the FAM, was constructed after an expansion of our literature review to 2006 and team discussion. The EFF provides new insights into possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion as they occur in both ill and non-ill states. In this paper, however, we consider only possible links in advanced cancer.
Conclusions
We propose that stressors associated with advanced cancer and its supportive treatment trigger declines in four systems—cognitive function, sleep quality, nutrition, and muscle endurance—and that these declines reduce one’s ability to adapt. While these systems each likely has its own effect on adaptation, we propose that the most important and serious effects arise from interactions among declines in cognitive function, sleep quality, nutrition, and muscle endurance.
Conclusions
Interventions for fatigue have been limited by a lack of understanding about its etiology. Hypotheses arising from the EFF` suggest a new direction for further study that focuses on interactions among cognitive function, sleep quality, nutrition, and muscle endurance.
Similar content being viewed by others
References
Aistars J (1987) Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum 14 (6):25–29
Ancoli-Israel S, Liu L, Marler M, Parker B, Jones B, Sadler G et al (2006) Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14:201–209
Argiles J, Costelli P, Carbo N, Pallares-Trujillo J, Lopez-Soriano F (1999) Tumor growth and nitrogen metabolism in the host. Int J Oncol 14:479–486
Barber M, Ross J, Voss A, Tisdale M, Fearon K (1999) The effect of an oral nutritional supplement enriched with fish oil on weight loss in patients with pancreatic cancer. Br J Cancer 81:80–86
Bartlett F (1953) Psychological criteria of fatigue. In: Floyd W, Welford A (eds) Symposium on fatigue. H. K. Lewis, London, pp 1–5
Baumgartner R (2000) Body composition in healthy aging. Ann NY Acad Sci 904:437–448
Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147:755–763
Baumgartner R, Wayne S, Waters D, Janssen I, Gallagher D, Morley J (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12:1995–2004
Beck S, Schwartz A (2000) Unrelieved pain contributes to fatigue and insomnia. Podium presentation at the Oncology Nursing Society’s 25th Congress, San Antonio, TX
Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J et al (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98:708–714
Bosaeus I, Daneryd P, Svanberg E, Lundholm K (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93:380–383
Bower J, Ganz P, Aziz N (2005) Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 67(2):277–280
Bower J, Ganz P, Aziz N, Fahey J, Cole S (2003) T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 95:1165–1168
Bozcik H, Dalmis B, Ozdogan M, Artac M, Savas B (2006) Quality of life in patients with advanced non-small cell lung cancer. Cancer Nurs 29(2):104–110
Brown D, McMillan D, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response and psychological distress in patients with advanced cancer. Cancer 103:377–382
Cameron C (1997) A theory of fatigue. Ergonomics 16(5):633–648
Clearfield M (2005) C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc 105:409–416
Cleeland C, Bennett G, Dantzer R, Dougherty P, Dunn A, Meyers C et al (2003) Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919–2925
Dallman P (1982) Manifestations of iron deficiency. Semin Hematol 19:19–30
Dallman P (1986) Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 6:13–40
Dantzer R (2001) Cytokine-induced sickness behaviour: where do we stand? Brain Behav Immun 15:7–24
Dantzer R, Bluthe R, Laye S, Bret-Dibat J, Parnet P, Kelley K (1998) Cytokines and sickness behavior. Ann NY Acad Sci 840:586–590
di Carlo E, Iezzi M, Pannellini T, Zaccardi F, Modesti A, Forni G et al (2001) Neutrophils in anti-cancer immunological strategies: old players in new games. J Hematother Stem Cell Res 10:739–748
Dodd M, Miaskowski C, Paul S (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(1):465–470
Fayad L, Keating M, Reuben J, O’Brien S, Lee B, Lerner S, Kurzrock R (2001) Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia:correlation with phenotypic characteristics and outcome. Blood 97:256–263
Fearon K, von Meyenfeldt M, Moses A, Van Geenen R, Gouma D, Giacosa A et al (2003) Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52(10):1479–1486
Field C, Johnson I, Schley P (2002) Nutrients and their role in host resistance to infection. J Leukoc Biol 71:16–32
Gardener G, Edgerton B, Senwiratne B, Barnard R, Chira Y (1977) Physical work capacity and metabolic stress in subjects with iron deficiency anemia. Am J Clin Nutr 30:910–917
Glaus A (1998) Fatigue in patients with cancer. Springer, Berlin
Grandjean E (1968) Fatigue: its physiological and psychological significance. Ergonomics 11(5):427–436
Horne R, Picard R (1979) Psychosocial risk factors for lung cancer. Psychosom Med 41:503–514
Jansen C, Miaskowski C, Dodd M, Dowling G, Kramer J (2005) Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol Nurs Forum 32(6):1151–1161
Janssen I, Baumgartner R, Ross R, Rosenberg I, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159(4):413–421
Kennedy G, Spence V, Underwood C, Belch J (2004) Increased neutrophil apoptosis in chronic fatigue syndrome. J Clin Pathol 57:891–893
Krueger J, Majde J, Obale F (2003) Sleep in host defense. Brain Behav Immun 17:S41–S47
Krueger J, Obal F, Fang J, Kubota T, Taishi P (2001) The role of cytokines in physiological sleep regulation. Ann NY Acad Sci 933:211–221
Kuzrock R (2001) The role of cytokines in cancer-related fatigue. Cancer 92(s6):1684–1688
Lee K, Cho M, Miaskowski C, Dodd M (2004) Impaired sleep and rhythms in persons with cancer. Sleep Med Rev 8:199–212
LeShan L, Worthington R (1956) Some recurrent life history patterns observed in patients with malignant disease. J Nerv Ment Dis 124:460–465
Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function—A randomized prospective study. Cancer 100:1967–1977
Lundstrom S, Furst C (2003) Symptoms in advanced cancer: relationship to endogenous cortisol levels. Palliat Med 17(6):503–508
Mazhar D, Gillmore R, Waxman J (2005) COX and cancer. QJM 98:711–718
Molassiotis A (1999) A correlational evaluation of tiredness and lack of energy in survivors of haematological malignancies. Eur J Cancer Care 8:19–25
Molle I, Steffensen R, Thiel S, Peterslund N (2006) Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. Eur J Haematol 77:19–26
Moore P, Dimsdale J (2002) Opioids, sleep, and cancer-related fatigue. Med Hypotheses 58(1):77–82
Morrow G, Shelke A, Roscoe J, Hickok J, Mustian K (2005) Management of cancer-related fatigue. Cancer Investig 23:229–239
Morse JM, Mitcham C, Hupcey JE, Tason MC (1996) Criteria for concept evaluation. J Adv Nurs 24:385–390
National Comprehensive Cancer Network (2006) Clinical practice guidelines in oncology: cancer-related fatigue, version 1. http://www.nccn.org/professionals/physician_gls/default.asp. Retrieved on Sept. 2, 2006
Olson K (2007) A new way of thinking about fatigue: A reconceptualization. Oncol Nurs Forum 34(1):93–99
Olson K, Morse JM (2005) Delineating the concept of fatigue using a pragmatic utility approach. In: Cutcliff J, McKenna H (eds) The essential concepts of nursing. Elsevier Science, Oxford, pp 141–159
Olson K, Krawchuk A, Qudussi T (2007) Fatigue in individuals with advanced cancer in active treatment and palliative settings. Cancer Nurs 30(6):1–10
Olson K, Tom B, Hewitt J, Whittingham J, Buchanan L, Ganton G (2002) Evolving routines: managing fatigue associated with lung and colorectal cancer. Qual Health Res 5:655–670
Olson K, Morse J, Smith J, Mayan M, Hammond D (2001) Linking the trajectories of illness and dying. Omega, J Death and Dying 42(4):293–308
Persson C, Glimelius B (2002) The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res 22(6B):3661–3668
Pratt V, Watanabe S, Bruera E, Mackey J, Clandinin M, Baracos B, Field C (2002) Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer 87:1370–1378
Pugh C, Kumagawa K, Fleshner M, Watkins L, Maier S, Rudy J (1998) Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun 12:212–229
Rhoten D (1982) Fatigue and the postsurgical patient. In: Norris C (ed) Concept clarification in nursing. Aspen, Rockville, MD, pp 277–300
Rich T, Innominato P, Boerner J, Mormont C, Iacobelli S, Baron B et al (2005) Elevated serum cytokines correlated with altered behaviour, serum cortisol rhythm, and dampened 24-hour rest–activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11:1757–1764
Sateia M, Silberfarb P (1998) Sleep. In: Doyle D, Hanks G, MacDonald N (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp 751–767
Savard J, Laroche L, Simard S, Ivers H, Morin C (2003) Chronic insomnia and immune function. Psychosom Med 65:211–221
Savard J, Morin C (2004) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908
Scott H, McMillan D, Forrest L, Brown D, McArdle C, Milroy R (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87:264–267
Sela R, Watanabe S, Nekolaichuk C (2005) Sleep disturbances in palliative cancer patients attending a pain and symptom control clinic. Palliat Support Care 3:23–31
Selye H (1952) The story of the adaptation syndrome. Acta, Montreal
Selye H (1956) The stress of life. McGraw Hill, New York
Selye H (1971) Hormones and resistance: part 1. Springer, New York
Stark M, Cimprich B (2003) Promoting attentional health: Importance to women’s lives. Health Care Women Int 24(2):93–102
Tisdale M (1999) Wasting in cancer. J Nutr 129(suppl 1):S243–S246
Tisdale M (2004) Cancer cachexia. Langebeck’s Arch Surg 389:299–305
Turner R, Anglin P, Burkes R, Couture F, Evans W, Goss G et al (2001) Epoetin Alfa in cancer patients. J Pain Symptom Manag 22(5):954–965
Viteri F, Torun B (1974) Anemia and physical work capacity. In: Garby L (ed) Clinics in haematology, vol 3. W. B. Saunders, London, pp 609–626
Witzig T, Silberstein P, Loprinzi C, Sloan J, Novotny P, Mailliard J, Rowland K, Alberts S, Krook J, Levitt R, Morton R (2005) Phase III, randomized, double blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 23(12):2606–2617
Woods L, Nail L, Gilster A, Winters K, Elsea C (2006) Cancer chemotherapy-related symptoms: Evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 33(3):535–542
Acknowledgments
Financial support was provided by the Alberta Heritage Foundation for Medical Research, the Canadian Institutes for Health Research, and the Alberta Palliative Care Research Initiative.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olson, K., Turner, A.R., Courneya, K.S. et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer. Support Care Cancer 16, 241–249 (2008). https://doi.org/10.1007/s00520-007-0298-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-007-0298-8